Kano Therapeutics

📍 Cambridge, United States🗓 Founded 2021👥 15 employees💰 Last funded Oct 2025
Biotechnology Research🌐 kanotherapeutics.com
Website LinkedIn
Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Kano Therapeutics?
Kano Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Kano Therapeutics last raise funding?
The most recent investment in Kano Therapeutics recorded on gritt.io was in October 2025.
When was Kano Therapeutics founded?
Kano Therapeutics was founded in 2021.
What industry is Kano Therapeutics in?
Kano Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kano Therapeutics based?
Kano Therapeutics is headquartered in Cambridge, United States.